TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial.

Annelie Johansson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.